- DNA sequencing company Illumina announced in a press release that it was acquiring Pacific Biosciences for approximately $US1.2 billion. Illumina expects to close the transaction in mid-2019.
- Illumina offered $US8 a share for Pacific Biosciences.Pacific Biosciences shares jumped 67% in late trading to $US7.51
- Pacific Biosciences is a company that also specialises in gene sequencing. Pacific Biosciences CEO Michael Hunkapiller said in the press release that the two companies have complementary technology capabilities for analysing genes, and when combined, will open “new frontiers of genomic utility.”
Business Insider Emails & Alerts
Site highlights each day to your inbox.